EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,351 | -94.5% | 11,862 | -50.6% | 0.00% | -100.0% |
Q2 2022 | $151,000 | -62.6% | 24,003 | -50.7% | 0.00% | -66.7% |
Q1 2022 | $404,000 | +818.2% | 48,659 | +478.9% | 0.00% | – |
Q4 2021 | $44,000 | -63.0% | 8,405 | -51.9% | 0.00% | -100.0% |
Q1 2020 | $119,000 | -33.5% | 17,462 | +3.3% | 0.00% | 0.0% |
Q2 2019 | $179,000 | – | 16,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
CAXTON CORP | 94,083 | $833,000 | 0.54% |